Beyond Pivotal Trials: Real-World Experience with Topical Androgen Receptor Inhibition
Dr. Andrei Metelitsa
While topical androgen receptor inhibition has demonstrated efficacy and tolerability in pivotal clinical trials, real-world data remain limited, particularly across diverse patient populations and in combination with other treatments.
Join Dr. Wei Jing Loo and Dr. Andrei Metelitsa for Beyond Pivotal Trials: Real-World Experience with Topical Androgen Receptor Inhibition on Saturday, November 14th, from 9:00–9:30 AM to explore the diverse real-world applications of topical androgen receptor inhibition in acne management. The session will examine real-world treatment practices with topical anti-androgen therapy based on a Canadian retrospective study of 291 patients, including a sub-analysis of patients with acne tarda. The discussion will explore the role of topical androgen receptor inhibition across diverse patient populations and clinical scenarios, including transgender patients with acne, as well as strategies drawn from clinical experience for combining oral and topical acne treatments. Through real-world data and candid discussion, you’ll gain a clearer picture of where topical androgen receptor inhibition fits into your practice.
- Explore the role of topical androgen receptor inhibition in the management of acne across diverse patient populations
- Evaluate real-world effectiveness and tolerability data for topical androgen receptor inhibitor therapy, used alone and in combination with other topical and oral therapies
- Apply evidence- and experience-informed strategies to build individualized combination regimens across diverse acne presentations